Fresh from closing an oversubscribed pre-IPO capital raise last month, cryopreservation company Vitrafy Life Sciences is gearing up for a float in the fourth quarter of this calendar year.
The business, which was only established in 2018, has appointed Bell Potter to manage the float, after the stockbroking firm also managed the company’s successful pre-IPO raise.
To read more, you will need an AFR subscription.
Cryopreservation is a critical bottleneck in cell therapy production. Explore a connected approach to preserving
Explore the challenges of salmon milt cryopreservation and share an innovative, quality-controlled system designed to
Evidence and methodology behind a controlled rapid cryopreservation ecosystem to reduce waste and improve post-thaw
"*" indicates required fields
